Business of Cannabis

Cannabis stocks carry the losses from Tuesday’s session into Wednesday morning, with US markets yet to open and all prices reflecting the 12 May close. As reported by Business of Cannabis, the sector closed Tuesday in broadly negative territory: 23 of 38 tracked tickers finished below th...

OVER 6,000 UK medical cannabis patients being treated with medical cannabis for anxiety, depression and PTSD have reported significant improvements with over 90% saying it surpassed the effectiveness of alternative medications.

The multi-clinic patient survey spanned four of the UK’s leading medical cannabis providers, namely:

Cannabis equities head into Tuesday’s pre-market session with the sector broadly divided, following a Monday close in which upward and downward pressure across the tracked universe roughly offset one another. As of 13:00 BST — with the New York open due at 14:30 BST — exchange-listed names reflect Monday’s settlement, while OTC-traded multi-state operators carry data from Fri...

Three and a half weeks after the Justice Department moved state-licensed medical cannabis to Schedule III, a cluster of practical consequences is landing simultaneously. Federal agencies are updating registration requirements and legal forms, the industry is calculating the limits of advertising relief, and one of the sector’s largest publicly listed operators has reported it...

IT’S been a while since Hungarian cannabis advocates were able to inhale a dose of optimism, but maybe that time is now.

With the new Government sworn-in last weekend we are at the end of a 20-year extended spell under the anti-drug premiership of Victor Orbán.

First elected in July 1998, Orbán wasted no time in declaring his hostility signifying that ‘people wh...